It’s time for a reckoning in pain medicine

KevinMD.com
17 November 2022
https://www.kevinmd.com/2022/11/its-time-for-a-reckoning-in-pain-medicine.html

More than a million Americans have died since the late 1990s from drug overdoses, with the vast majority dying from an opioid overdose. Substance abuse treatment providers report that 80 percent of illicit opioid users got addicted after being prescribed opioid painkillers. 

‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever

Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions

Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374

Studies Aim to Find Long COVID Treatments

VOA Learning English
31 October 2022
https://learningenglish.voanews.com/a/studies-aim-to-find-long-covid-treatments/6796700.html

Should Doctors Consider Low Dose Naltrexone for Long COVID?

The People's Pharmacy
20 October 2022
https://www.peoplespharmacy.com/articles/should-doctors-consider-low-dose-naltrexone-for-long-covid

Low Dose Naltrexone (LDN) Increases Endorphin Levels

RecentlyHeard
30 September 2022
https://recentlyheard.com/2022/09/30/low-dose-naltrexone-ldn-increases-endorphin-levels/

When prescribed in the low dose form, LDN can help with a multitude of different ailments and issues such as anxiety, depression, inflammation, cancers, chronic pain, immune system dysfunction, and other mental health-related issues, as well.  

Novel Therapies for Centralized Pain: a Brief Review

Curr Pain Headache Rep
28 September 2022
https://pubmed.ncbi.nlm.nih.gov/36169808/

Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord

Life Sci
04 September 2012
https://pubmed.ncbi.nlm.nih.gov/22820166/

Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords

Behav Brain Res
11 February 2010
https://pubmed.ncbi.nlm.nih.gov/19799935/